Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Brossart

Showing results (61-70 of 266) with videos related to

Pageof 27
Sort By:
Frontiers in Immunology|December 15, 2022
Baseline immune signature score of Tregs × HLA-DR<sup>+</sup>CD4<sup>+</sup> T cells × PD1<sup>+</sup>CD8<sup>+</sup> T cells predicts outcome to immunotherapy in cancer patientsRebekka Mispelbaum, Sandra Tessa Hattenhauer, Stefanie Andrea Erika Held, et al.
Blood|December 29, 2005
Epithelial-specific transcription factor ESE-3 is involved in the development of monocyte-derived DCsSilke Appel, Anita Bringmann, Frank Grünebach, et al.
Blood|January 16, 2007
TLR ligands differentially affect uptake and presentation of cellular antigensMarkus Michael Weck, Frank Grünebach, Daniela Werth, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|July 5, 2021
Conception and Feasibility of a Digital Tele-Guided Abdomen, Thorax, and Thyroid Gland Ultrasound Course for Medical Students (TELUS study)Elena Höhne, Florian Recker, Erik Schmok, et al.
Plos One|October 7, 2014
Simultaneous deletion of p21Cip1/Waf1 and caspase-3 accelerates proliferation and partially rescues the differentiation defects of caspase-3 deficient hematopoietic stem cellsCarmen Carrillo García, Tamara Riedt, Jin Li, et al.
Hematology (Amsterdam, Netherlands)|May 19, 2023
Treatment of acute myeloid leukaemia in older patients - scope of intensive therapy? - A retrospective analysisKarin Mayer, Michael Serries, Corinna Hahn-Ast, et al.
Haematologica|October 14, 2003
Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cellsVolker L Reichardt, Caterina Milazzo, Wolfram Brugger, et al.
Frontiers in Immunology|October 12, 2023
Spoilt for choice: different immunosuppressive potential of anaplastic lymphoma kinase inhibitors for non small cell lung cancerAnnkristin Heine, Stefanie Andrea Erika Held, Solveig Nora Daecke, et al.
Cancers|November 9, 2024
The Immunomodulatory Effect of Different FLT3 Inhibitors on Dendritic CellsSebastian Schlaweck, Alea Radcke, Sascha Kampmann, et al.
Cancer Research|June 3, 2006
BCR-ABL is not an immunodominant antigen in chronic myelogenous leukemiaFrank Grünebach, Valbona Mirakaj, Valdete Mirakaj, et al.
Pageof 27

Showing results (61-70 of 266) with videos related to

Sort By:
Pageof 27
Frontiers in Immunology|December 15, 2022
Baseline immune signature score of Tregs × HLA-DR<sup>+</sup>CD4<sup>+</sup> T cells × PD1<sup>+</sup>CD8<sup>+</sup> T cells predicts outcome to immunotherapy in cancer patientsRebekka Mispelbaum, Sandra Tessa Hattenhauer, Stefanie Andrea Erika Held, et al.
Blood|December 29, 2005
Epithelial-specific transcription factor ESE-3 is involved in the development of monocyte-derived DCsSilke Appel, Anita Bringmann, Frank Grünebach, et al.
Blood|January 16, 2007
TLR ligands differentially affect uptake and presentation of cellular antigensMarkus Michael Weck, Frank Grünebach, Daniela Werth, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|July 5, 2021
Conception and Feasibility of a Digital Tele-Guided Abdomen, Thorax, and Thyroid Gland Ultrasound Course for Medical Students (TELUS study)Elena Höhne, Florian Recker, Erik Schmok, et al.
Plos One|October 7, 2014
Simultaneous deletion of p21Cip1/Waf1 and caspase-3 accelerates proliferation and partially rescues the differentiation defects of caspase-3 deficient hematopoietic stem cellsCarmen Carrillo García, Tamara Riedt, Jin Li, et al.
Hematology (Amsterdam, Netherlands)|May 19, 2023
Treatment of acute myeloid leukaemia in older patients - scope of intensive therapy? - A retrospective analysisKarin Mayer, Michael Serries, Corinna Hahn-Ast, et al.
Haematologica|October 14, 2003
Idiotype vaccination of multiple myeloma patients using monocyte-derived dendritic cellsVolker L Reichardt, Caterina Milazzo, Wolfram Brugger, et al.
Frontiers in Immunology|October 12, 2023
Spoilt for choice: different immunosuppressive potential of anaplastic lymphoma kinase inhibitors for non small cell lung cancerAnnkristin Heine, Stefanie Andrea Erika Held, Solveig Nora Daecke, et al.
Cancers|November 9, 2024
The Immunomodulatory Effect of Different FLT3 Inhibitors on Dendritic CellsSebastian Schlaweck, Alea Radcke, Sascha Kampmann, et al.
Cancer Research|June 3, 2006
BCR-ABL is not an immunodominant antigen in chronic myelogenous leukemiaFrank Grünebach, Valbona Mirakaj, Valdete Mirakaj, et al.
Pageof 27